Cite
Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer.
MLA
El-Tanani, Mohamed, et al. “Matrix Metalloproteinase 2 Is a Target of the RAN-GTP Pathway and Mediates Migration, Invasion and Metastasis in Human Breast Cancer.” Life Sciences, vol. 310, Dec. 2022, p. 121046. EBSCOhost, https://doi.org/10.1016/j.lfs.2022.121046.
APA
El-Tanani, M., Platt-Higgins, A., Lee, Y.-F., Al Khatib, A. O., Haggag, Y., Sutherland, M., Zhang, S.-D., Aljabali, A. A. A., Mishra, V., Serrano-Aroca, Á., Tambuwala, M. M., & Rudland, P. S. (2022). Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer. Life Sciences, 310, 121046. https://doi.org/10.1016/j.lfs.2022.121046
Chicago
El-Tanani, Mohamed, Angela Platt-Higgins, Yin-Fai Lee, Arwa Omar Al Khatib, Yusuf Haggag, Mark Sutherland, Shu-Dong Zhang, et al. 2022. “Matrix Metalloproteinase 2 Is a Target of the RAN-GTP Pathway and Mediates Migration, Invasion and Metastasis in Human Breast Cancer.” Life Sciences 310 (December): 121046. doi:10.1016/j.lfs.2022.121046.